First human test for potential peanut allergy therapy begins
NCT ID NCT05476497
Summary
This is an early safety study testing a new potential treatment called VLP Peanut for people with peanut allergies. The main goal is to see if the treatment is safe and well-tolerated in a small group of healthy adults and adults with peanut allergy. Researchers will also look for early signs that it might help reduce allergic reactions to peanuts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Trio Clinical Trials, LLC.
Houston, Texas, 77008, United States
-
University of Arizona
Tucson, Arizona, 85724, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of South Florida
Tampa, Florida, 33613, United States
-
University of Wisconsin School of Medicine and Public Health Asthma, Allergy, and Pulmonary Clinical Research
Madison, Wisconsin, 53792-9988, United States
-
Washington University School of Medicine
St Louis, Missouri, 63141, United States
Conditions
Explore the condition pages connected to this study.